Clinical Trial Update: TTHX1114(NM141) in Combination With DWEK/DSO [Phase 2]

View source ↗

Summary

Phase 2 trial update for TTHX1114 (NM141) in combination with DWEK/DSO for Fuchs' Endothelial Dystrophy has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fuchs Dystrophy
• Fuchs Endothelial Dystrophy

Drugs mentioned

• DWEK/DSO
• TTHX1114 (NM141) (TTHX1114)

Snippet

Sponsor: Trefoil Therapeutics, Inc. | Conditions: Fuchs' Endothelial Dystrophy, Fuchs Dystrophy | Phase 2 | Status: COMPLETED